Clinical Trial

The Impact of Medical TV Drama in Improving Literacy on Neurocysticercosis

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 4, 2025 (before its estimated February 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled trial evaluates whether exposure to a medical television drama improves knowledge of neurocysticercosis (NCC) among young adults. Sixty participants aged 18-35 will be randomly assigned to either an intervention group, which will watch a medically relevant TV episode (House M.D., Season 1, Episode 1), or a control group with no media exposure. Both groups will complete pre- and post-test questionnaires assessing knowledge of NCC. The primary outcome is change in NCC-related knowledge. Secondary outcomes include motivation to seek further health information and perceived credibility of the media source
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-28.
Trial Details
NCT Number NCT07208656
Lead Sponsor Cephas Health Research Initiative Inc, Ibadan, Nigeria
Conditions Neurocysticercosis, Health Literacy, Epilepsy
Enrollment 60 participants
Start Date 2025-12-15
Primary Completion 2026-02-15 (estimated)
Study Completion 2026-04-15 (estimated)
Updated on ClinicalTrials.gov 2025-12-04